| Mepha Pharma AG - Buprenorphin-Mepha 2 mg, Sublingualtabletten | | 65188 | | 02 | | Buprenorphin-Mepha 2 mg | | Sublingualtabletten | | N07BC01 | | Buprenorphine | | 12.12.2014 | | |
| | Composition | | buprenorphinum 2 mg ut buprenorphini hydrochloridum 2.16 mg, magnesii stearas, crospovidonum, natrii citras anhydricus corresp. natrium 0.468 mg, povidonum K 29-32, acidum citricum, amylum pregelificatum, mannitolum, lactosum monohydricum 43.9 mg, E 110 0.19 mg, pro compresso. | | Packungsbestandteile | | Sublingual tablets | | | | | Active Agent | Dose |
|---|
| Buprenorphine | 2 mg |
| | BAG: Active Agent | Dose |
|---|
| Buprenorphine | 2 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Citric Acid | | | | Amylum Pregelificatum | | | | Crospovidonum | | | | E 110 | 0.19 mg | color. | | Lactose Monohydrate | 43.9 mg | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Citras Anhydricus | | | | Povidonum K | 29-32 | | | Pro Compresso | | |
| |
| |
|
